Jiangsu Yutian Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise specializing in the research, development, production, and sales of innovative APIs and CDMO services. Dedicated to providing high-quality active pharmaceutical ingredients (APIs) and intermediates to major domestic pharmaceutical companies, the company's products are also exported to dozens of countries, including Europe, Japan, South Korea, and India. It is recognized as a National High-Tech Enterprise, a Municipal Science and Technology "Little Giant" Enterprise, and one of the key enterprises in the Zhonghua Medicine Port's new pharmaceutical industry base.

Yutian Pharmaceutical consistently prioritizes research and development as the cornerstone of sustainable growth, making it one of the domestic pharmaceutical companies with substantial investment in R&D. With its Lianyungang R&D Center serving as the scientific hub, and in collaboration with Hangzhou Kechao Biotechnology, Lianyungang Vanke Biotechnology, and Heilongjiang Dinuo Pharmaceutical, the company continues to enhance its independent innovation capabilities, forming a positive "one driving three" development pattern. Yutian Pharmaceutical operates two production bases in Lianyungang, Jiangsu, and Jiamusi, Heilongjiang. It has been accredited as a National High-Tech Enterprise, Provincial Engineering Technology Research Center, Jiangsu Provincial Gazelle Enterprise, Jiangsu Provincial Sci-Tech SME, Grade II Safety Standardization Enterprise, and a Provincial Integration of Informatization and Industrialization Demonstration Enterprise. The company has also obtained combined GMP and registration on-site inspection certifications for its API varieties, undertaken multiple provincial and municipal sci-tech projects, including achievements transformation initiatives, secured dozens of authorized patents and trademarks, and achieved ISO9000 and ISO14000 certifications. These honors signify that the company's drug production quality and management standards are at the forefront of the national pharmaceutical industry.